Clinical Trial Update: Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating docetaxel with or without TAK-117 (MLN1117) in locally advanced or metastatic non-small cell lung cancer; the study status is termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• TAK-117 (MLN1117) (MLN1117)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-02-07